How to prescribe Seretide
Seretide in asthma
Seretide is indicated in the regular treatment of patients aged 4 and over with asthma, where use of a combination product (long-acting ß2–agonist, LABA, and inhaled corticosteroid, ICS) is appropriate:
- Patients not adequately controlled on both ICS and 'as-needed' short-acting ß2-agonist (SABA).
- Patients already adequately controlled on both ICS and LABA. 1
Seretide in COPD
Seretide 500 Diskus is indicated for the symptomatic treatment of COPD patients with FEV1 <60% predicted normal (pre-bronchodilator) with repeated exacerbations and significant symptoms despite regular bronchodilator therapy 1
Inhalers and devices
Seretide Evohaler is the only salmeterol/fluticasone propionate combination licensed for use with the Volumatic spacer device.
Using an inhaler is a skill that must be learnt and maintained in order for medication to be delivered effectively. Poor inhaler technique may lead to poor asthma control, increased risk of exacerbations and increased risk of adverse effects. Additionally, different spacers are associated with different systemic absorption of fluticasone propionate, so for safety/tolerability reasons patients should not switch from one spacer device to another. All healthcare professionals should be encouraged to assess asthma control, adherence and inhaler technique at every visit 1.
In order to support this important goal of disease management we have provided leaflets and videos designed to help you to help your patients with correct inhaler technique.
Inhaler technique leaflets
- How to use your Seretide Diskus (PDF)
- How to use your Seretide Evohaler (PDF)
- How to use your Seretide Evohaler with a volumatic spacer device (PDF)
Inhaler technique videos
How to use your Evohaler:
How to use your Evohaler with a spacer:
Seretide in paediatric patients
For further information on how Seretide offers an effective asthma treatment for children aged four years and older, see our paediatrics page.
Seretide safety and tolerability
For all Seretide safety and tolerability information please review the Seretide Summary of Product Characteristics. The following sections contain the safety and tolerability information:
4.4 Special warnings and precautions for use
4.5 Interaction with other medicinal products and other forms of interaction
4.6 Fertility, pregnancy and lactaction
4.7 Effects on ability to drive and use machines
4.8 Undesirable affects
- Seretide Diskus Summary of Product Characteristics (Date accessed - 03 July 2015)
- Seretide Evohaler Summary of Product Characteristics (Date accessed - 03 July 2015)
- Global strategy for asthma management and prevention, 2016; accessed 10th May 2016